Search Tufts Medicine

Displaying 1 - 20 of 213
page
...
The Tufts Medical Center Cancer Center in Boston is home to expert physicians, scientists and researchers passionate about fighting cancer.
Cancer Center Research
Health + well-being
calendar-event May 20, 2024 clock 5:00pm - 6:30pm map-pin Dermatology Clinic - 13th floor of the Biewend Building
Summer is just around the corner – are you ready? And very importantly, is your skin ready? In honor of Melanoma/Skin cancer Awareness Month, Tufts Medical Center Dermatology is offering free skin cancer screenings on Monday, May 20, from 5pm-6:30pm in their clinic on the 13th floor of the Biewend Building. No appointment needed, individuals will be seen on a first come, first served basis. 
clinical trial
...

Breast cancer (BC) is the leading cause of cancer and the second most common cause of cancer related mortality in the United States. Although the prognosis of patients with BC has greatly improved over the past few years, there are still many unanswered questions. There is growing interest in identifying markers for treatment de-escalation or intensification in early and advanced breast cancer as well as in ductal carcinoma in situ (DCIS). Additionally, there are well known differences in disease biology and outcomes in groups from diverse genetic ancestry.
Support groups
calendar-event Jun 11, 2024 clock 6:00 pm - 7:30 pm map-pin Online
While we continue to practice social distancing, we are excited to offer this Support Group online with virtual Zoom meetings.This group is designed for current and newly diagnosed patients to share ideas, concerns and stories in a supportive environment.
clinical trial
...

This is an open label, multicenter, single arm phase II study to evaluate the efficacy and safety of ribociclib and ET in patients with locoregional recurrence of HR-positive, HER2-negative breast cancer.
Support groups
calendar-event Jun 11, 2024 clock 2:30 pm - 4:00 pm map-pin Online
The Us TOO® Prostate Support Group offers fellowship, peer counseling, education and discussion regarding treatment options for newly diagnosed prostate cancer patients. Significant others are also encouraged to attend.While we continue to practice social distancing, this support group will be facilitated through an online Zoom meeting.
page
...
With the explosion in novel cancer therapies, cancer outcomes have improved dramatically resulting in a growing population of cancer survivors. Simultaneously, there has been a rise in cardiovascular side effects of these cancer therapies that is limiting quality of life and life expectancy of cancer survivors.
clinical trial
...

This research is to determine the performance characteristics of a urine-based test for the detection of recurrent bladder cancer in low-grade patients who have been treated according to standard practice and are undergoing routine surveillance cystoscopy. The cystoscopy is regarded as the gold standard for determining recurrence of cancer. The Co-Principal Investigator at Tufts University has developed a urine-based monitoring test of bladder cancer, using imaging of the surface of cells extracted from the patients’ urine.
page
...
A research program that targets the discovery and application of nutritional and dietary approaches to prevent colorectal cancer.
Joel B. Mason, MD Laboratory
page
...
Patients and visitors using the main entrance of the hospital are welcome to park in the central parking lot or parking garage at our campuses.
page
...
The Jaffe laboratory is focused on understanding the molecular mechanisms by which blood vessels become dysfunctional to lead to common cardiovascular conditions, including heart attack, stroke, high blood pressure, in-stent restenosis, vein graft failure and heart failure. We are interested in understanding how traditional risk factors like aging, obesity, high blood pressure or high cholesterol, or new risk factors like novel cancer treatments, cause blood vessels to become diseased. We are also focused on understanding sex differences in how these cardiovascular diseases develop, in order to identify sex-specific precision medicine strategies.
clinical trial
...

This phase III trial compares the effects of olanzapine versus megestrol acetate in treating loss of appetite in patients with cancer that has spread to other places in the body (advanced). Olanzapine may stimulate and increase appetite. This study aims to find out if olanzapine is better than the usual approach (megestrol acetate) for stimulating appetite and preventing weight loss.